Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Healthcare Services Group, Inc. Reports Q1 2022 Results: https://mms.businesswire.com/media/20200211006058/en/734402/5/HCSG_Logo.jpg
Healthcare Services Group, Inc. Reports Q1 2022 Results


Healthcare Services Group, Inc. (NASDAQ:HCSG) (the “Company”) reported for the three months ended March 31, 2022 revenue of $426.8 million and net income of $11.3 million, or $0.15 per basic and

Fix Price Group Ltd. : announcement publication of the amended BVI Articles and Cyprus Articles which will be effective as of the Redomiciliation
Fix Price Group Ltd. : announcement publication of the amended BVI Articles and Cyprus Articles which will be effective as of the Redomiciliation
Fix Price Group Ltd. : announcement publication of the amended BVI Articles and Cyprus Articles which will be effective as of the Redomiciliation
Navidea Biopharmaceuticals Announces Updated Third-Party Asset Valuation of Tc99m Tilmanocept for Indications in Rheumatoid Arthritis for U.S. and EU Markets: https://mms.businesswire.com/media/20191107006076/en/389794/5/navidea_cmyk.jpg
Navidea Biopharmaceuticals Announces Updated Third-Party Asset Valuation of Tc99m Tilmanocept for Indications in Rheumatoid Arthritis for U.S. and EU Markets


Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today

Navidea Biopharmaceuticals Announces Positive Preliminary Results of Its Ongoing Phase 2B Study Comparing Tc99m Tilmanocept Imaging with Histopathology of Joints from Patients with Rheumatoid Arthritis: https://mms.businesswire.com/media/20191107006076/en/389794/5/navidea_cmyk.jpg
Navidea Biopharmaceuticals Announces Positive Preliminary Results of Its Ongoing Phase 2B Study Comparing Tc99m Tilmanocept Imaging with Histopathology of Joints from Patients with Rheumatoid Arthritis


Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today

NICE Actimize Cloud-Based SURVEIL-X Wins Market Surveillance Category in WATERS 2022 Sell-Side Technology Awards: https://mms.businesswire.com/media/20191203005409/en/615391/5/NICE_inContact.jpg
NICE Actimize Cloud-Based SURVEIL-X Wins Market Surveillance Category in WATERS 2022 Sell-Side Technology Awards


NICE Actimize, a NICE (NASDAQ: NICE) business, has been chosen as the winner in the Market Surveillance category in the prestigious WATERS Sell-Side Magazine 2022 Technology Awards competition

Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc.
Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc.
Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc.
SThree: Result of Annual General Meeting
SThree: Result of Annual General Meeting
SThree: Result of Annual General Meeting
Turkiye Garanti Bankasi A.S.: Coupon payment of  Covered Bonds to Qualified Investors
Turkiye Garanti Bankasi A.S.: Coupon payment of Covered Bonds to Qualified Investors
Turkiye Garanti Bankasi A.S.: Coupon payment of Covered Bonds to Qualified Investors
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Participate at Upcoming  Investor Conferences
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Participate at Upcoming Investor Conferences
DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Participate at Upcoming Investor Conferences
DGAP-News: Photon Energy Group Announces 2022 Financial Guidance
DGAP-News: Photon Energy Group Announces 2022 Financial Guidance
DGAP-News: Photon Energy Group Announces 2022 Financial Guidance
Achiko AG: Achiko AG Signs Major Marketing and Sales Agreement with the World's Largest Islamic Association for its AptameX Covid-19 rapid test
Achiko AG: Achiko AG Signs Major Marketing and Sales Agreement with the World's Largest Islamic Association for its AptameX Covid-19 rapid test
Achiko AG: Achiko AG Signs Major Marketing and Sales Agreement with the World's Largest Islamic Association for its AptameX Covid-19 rapid test
DGAP-News: Plus X Award 2022: Gigaset retail brand of the year again
DGAP-News: Plus X Award 2022: Gigaset retail brand of the year again
DGAP-News: Plus X Award 2022: Gigaset retail brand of the year again
Achiko AG: Achiko secures up to CHF12m equity and debt financing lines with RiverFort  over 3 years
Achiko AG: Achiko secures up to CHF12m equity and debt financing lines with RiverFort over 3 years
Achiko AG: Achiko secures up to CHF12m equity and debt financing lines with RiverFort over 3 years
DGAP-News: Compleo Charging Solutions AG: Framework agreement on wallboxes: Compleo now the hardware partner for ChargeOne
DGAP-News: Compleo Charging Solutions AG: Framework agreement on wallboxes: Compleo now the hardware partner for ChargeOne
DGAP-News: Compleo Charging Solutions AG: Framework agreement on wallboxes: Compleo now the hardware partner for ChargeOne
SWEF: March 2022 NAV
SWEF: March 2022 NAV
SWEF: March 2022 NAV
Genel Energy PLC: Changes to Director's responsibilities
Genel Energy PLC: Changes to Director's responsibilities
Genel Energy PLC: Changes to Director's responsibilities
Multitude SE: Aksels Neilands appointed as Chief Marketing Officer of SweepBank
Multitude SE: Aksels Neilands appointed as Chief Marketing Officer of SweepBank
Multitude SE: Aksels Neilands appointed as Chief Marketing Officer of SweepBank
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
Genel Energy PLC: Notice of dividend currency exchange rate
Genel Energy PLC: Notice of dividend currency exchange rate
Genel Energy PLC: Notice of dividend currency exchange rate
DGAP-News: APONTIS PHARMA: START study published in scientific journal - Cost reduction in the treatment of cardiovascular patients by Single Pill therapy
DGAP-News: APONTIS PHARMA: START study published in scientific journal - Cost reduction in the treatment of cardiovascular patients by Single Pill therapy
DGAP-News: APONTIS PHARMA: START study published in scientific journal - Cost reduction in the treatment of cardiovascular patients by Single Pill therapy
DGAP-News: Fandifi Technology takes fan engagement to a new level with Gamification and NFTs
DGAP-News: Fandifi Technology takes fan engagement to a new level with Gamification and NFTs
DGAP-News: Fandifi Technology takes fan engagement to a new level with Gamification and NFTs
Evolva achieves important product-related milestones with global customer, triggering revenues of more than 20% of FY21 total revenues
Evolva achieves important product-related milestones with global customer, triggering revenues of more than 20% of FY21 total revenues
Evolva achieves important product-related milestones with global customer, triggering revenues of more than 20% of FY21 total revenues